Docebo
Docebo's revenue rose 11.9% to $243 million in fiscal 2025. Its operating margin was 9.6%, down from 9.8% a year earlier. Free cash flow was $27 million, down 2.9%. The diluted share count fell 5.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity.
What Docebo does
Docebo sells online training software to businesses. Its learning management system, run in the cloud, lets companies build, deliver and track training courses for their own staff and for outside groups such as partners and customers. The platform uses AI to help create courses and tests, recommend content and map employees' skills. Its customers include Thomson Reuters, HP, Google, Booking.com, L'Oréal and Heineken.
Customers pay a subscription, usually for one to three years, priced by the number of learners and the modules they use. Subscriptions brought in 94% of revenue in 2025. Revenue was US$242.7 million, and about 74% of it came from customers in North America, with most of the rest from Europe. Docebo competes with Cornerstone OnDemand, SAP SuccessFactors and SAP Litmos, with consulting firms that adapt free software such as Moodle, and with free options such as YouTube.
The company is based in Toronto and had more than 900 employees in eight offices, including Biassono in Italy, Atlanta, London, Paris and Munich. It sells in about 60 countries and counted nearly 3,500 companies as customers at the end of 2025. Its platform runs on Amazon Web Services' data centers.
Its biggest risks, as it describes them
- Rivals that are larger and better funded, in a market where new competitors keep appearing.
- Customers may not renew their subscriptions, may cut back, or may not expand their use of the platform.
- It may fail to keep up with new technology, including AI, or with what customers need.
- A security breach could expose customer data, harm its reputation and cost it customers.
- Its reliance on Amazon Web Services and other outside software to run its platform.
Income statement
From fiscal 2022 to 2025, earnings per share grew 82.7% a year and net income 75.0% a year, as buybacks cut the share count by 14%.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 215 | 216 | 72 | 92 | 74 |
| Debt incl. finance leases | 0 | 0 | 0 | 0 | 0 |
| Net debt (negative means net cash) | −215 | −216 | −72 | −92 | −74 |
| Net debt to EBITDA | — | −33.2x | — | −3.8x | −2.8x |
| Debt to equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | — | — | — | — | — |
| Current ratio | 3.6x | 3.1x | 1.3x | 1.2x | 1.2x |
| Quick ratio | 3.6x | 3.1x | 1.3x | 1.2x | 1.2x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 6 of 9 | 7 of 9 | 5 of 9 |
| Rule of 40 | 35.0% | 32.9% | 23.1% |
| Altman Z'' | −2.78 | −1.42 | −0.68 |
| Accruals ratio | −5.9% | −1.4% | 4.7% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Fail | Fail | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Pass | Pass | Fail |
| F-score | 6 of 9 | 7 of 9 | 5 of 9 |
Compare
Put Docebo side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Docebo | FY25 | 11.9% | 9.6% | 11.2% | — | −2.8x | 5 | |
| OneSpan | FY25 | 0.0% | 19.9% | 20.8% | — | — | — | Compare |
| Definitive Healthcare | FY25 | −4.2% | −92.9% | 15.3% | −38.3% | — | 5 | Compare |
| VTEX | FY25 | 6.1% | 7.5% | 13.4% | 39.9% | −9.0x | 6 | Compare |
| C3.ai | FY26 | −35.7% | −199.2% | −76.8% | — | — | — | Compare |
7 years of figures
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 41 | 63 | 104 | 143 | 181 | 217 | 243 |
| Revenue growth | — | 51.8% | 65.7% | 37.1% | 26.5% | 20.0% | 11.9% |
| Gross profit | 33 | 51 | 84 | 115 | 146 | 176 | 195 |
| Research and development | 9 | 13 | 20 | 25 | 36 | 44 | 50 |
| Operating income | −10 | −8 | −13 | 4 | −4 | 21 | 23 |
| Net income | −12 | −8 | −14 | 7 | 3 | 27 | 38 |
| Diluted EPS (US$) | −0.49 | −0.28 | −0.41 | 0.21 | 0.08 | 0.86 | 1.28 |
| Diluted shares (millions) | 24 | 29 | 33 | 34 | 34 | 31 | 29 |
| Cash flow | |||||||
| Cash from operations | −5 | 5 | −3 | 2 | 16 | 29 | 28 |
| Capital expenditure | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Free cash flow | −5 | 4 | −4 | 1 | 15 | 28 | 27 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 18 | 0 |
| Acquisitions | 0 | 2 | 0 | 1 | 9 | 0 | 0 |
| Stock-based compensation | 1 | 2 | 2 | 5 | 6 | 7 | 6 |
| Balance sheet at fiscal year end | |||||||
| Cash and short-term investments | 46 | 220 | 215 | 216 | 72 | 92 | 74 |
| Debt incl. finance leases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 64 | 254 | 268 | 284 | 158 | 191 | 207 |
| Total liabilities | 32 | 54 | 78 | 92 | 108 | 133 | 133 |
| Shareholders' equity | 31 | 200 | 191 | 192 | 51 | 58 | 74 |
| Margins and ratios | |||||||
| Gross margin | 79.8% | 81.7% | 80.1% | 80.3% | 80.9% | 81.0% | 80.3% |
| Operating margin | −23.7% | −12.1% | −12.9% | 2.9% | −2.0% | 9.8% | 9.6% |
| Net margin | −28.8% | −12.7% | −13.1% | 4.9% | 1.6% | 12.3% | 15.5% |
| Free cash flow margin | −11.9% | 5.9% | −4.2% | 0.8% | 8.5% | 12.9% | 11.2% |
| Rule of 40 (growth + FCF margin) | — | 57.7% | 61.5% | 37.9% | 35.0% | 32.9% | 23.1% |
| Return on capital | — | — | — | — | — | — | — |
| Return on equity | — | −6.9% | −7.0% | 3.7% | 2.3% | 49.3% | 56.9% |
| Return on assets | — | −5.0% | −5.2% | 2.5% | 1.3% | 15.3% | 18.9% |
| Net debt to EBITDA | — | — | — | −33.2x | — | −3.8x | −2.8x |